Analysis of ACTA2 and pdgf-rα mRNA using real-time quantitative PCR. RNA was isolated, reverse-transcribed, and αSMA, pdgf-rα (Mm00440701_m1), and β-2-microglobulin mRNA were quantified using ...

Four weeks later, levels of IL-6, IP-10, MCP-1, VEGF and PDGF-AA were decreased in the eyes that received triamcinolone, whereas only VEGF levels were lower in eyes that received bevacizumab.

PDGF production and PDGF mRNA synthesis are decreased by ingestion of n-3 fatty acids. [38] In summary, the n-3 PUFAs have predominantly antiatherogenic properties ( Table III). Most of these ...

But this is the first phase-IIb randomised clinical trial to test the investigational mRNA vaccine in patients. Could Covid vaccine technology crack cancer? Patients taking Keytruda for advanced ...

A deadly disease for baby Asian elephants is the target for an mRNA vaccine that has been administered to an elephant for the first time. Elephant endotheliotropic herpesvirus (EEHV) is the number ...

"The advantage of mRNA is that, in theory, we can make a COVID-19 vaccine, we can make H5N1 vaccines, but also many other vaccines and importantly also therapeutics," Friede told reporters.

Moderna stock plummeted on new guidance for $3 billion to $3.5 billion in full-year sales. Is MRNA stock now a sell? Investors are rewarding biotech companies that can trim the fat these days.

Bird flu snapshot: This is the latest installment in a series of regular updates on the H5N1 flu outbreak in dairy cows that STAT is publishing on Monday mornings. To read future updates, you can ...

Get up to 10 years of daily historical stock prices & volumes. The "Close/Last" is the “adjust consolidated close price”. Data provided by Edgar Online. The net and percent change in the ...

Moderna stock, which lost 27% of its value over two days, tumbled again Monday on a rare downgrade amid uncertainty for its vaccines.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines ...